Bio Green Med Solution Q1 Net Loss $0.2M; Preferred Stock Delisted

Bio Green Med Solution reported a net loss of $0.2 million for the first quarter of 2026, alongside $0.8 million in product revenue from its fire safety protection and distribution business, acquired in September 2025. The company achieved a significant reduction in general and administrative expenses, which decreased by $3.8 million to $0.4 million. In a notable corporate action, the company's 6% Convertible Exchangeable Preferred Stock was delisted from The Nasdaq Capital Market in March 2026, though its common stock remains listed. A quarterly cash dividend of $0.15 per share was paid on the preferred stock on May 1, 2026, and the company estimates its $3.3 million in cash and cash equivalents will fund planned expenditures into Q4 2026.